| RS1568497199 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, Congenital multicore myopathy with external ophthalmoplegia |
| RS1568498107 |
SMARCA4
|
Health Risk |
Likely pathogenic |
Rhabdoid tumor predisposition syndrome 2, Neoplasm |
| RS1568499702 |
BCKDHA
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS1568501059 |
RYR1
|
Health Risk |
Likely pathogenic |
Malignant hyperthermia, susceptibility to |
| RS1568501271 |
RYR1
|
Health Risk |
Likely pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS1568501473 |
RYR1
|
Health Risk |
Pathogenic |
Congenital multicore myopathy with external ophthalmoplegia, Congenital multicore myopathy with external ophthalmoplegia |
| RS1568501702 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS1568503046 |
RYR1
|
Health Risk |
Likely pathogenic |
— |
| RS1568503938 |
BCKDHA
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS1568504941 |
CIC
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 45 |
| RS1568506608 |
BCKDHA
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS1568507151 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Episodic ataxia type 2 |
| RS1568507354 |
RYR1
|
Health Risk |
Likely pathogenic |
Central core myopathy, Malignant hyperthermia |
| RS1568508047 |
BCKDHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS1568509739 |
RYR1
|
Health Risk |
Likely pathogenic |
— |
| RS1568509890 |
TCF4
|
Health Risk |
Pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS1568509937 |
ITPA
|
Health Risk |
Pathogenic |
Inosine triphosphatase deficiency, Inosine triphosphatase deficiency |
| RS1568510163 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS1568510406 |
RYR1
|
Health Risk |
Pathogenic |
Central core myopathy, Central core myopathy |
| RS1568512728 |
CSNK2A1
|
Health Risk |
Likely pathogenic |
Okur-Chung neurodevelopmental syndrome, Okur-Chung neurodevelopmental syndrome |
| RS1568514017 |
RYR1
|
Health Risk |
Likely pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS1568514116 |
CACNA1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Episodic ataxia type 2, Inborn genetic diseases |
| RS1568514371 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Episodic ataxia type 2, Episodic ataxia type 2 |
| RS1568515222 |
IL12RB1
|
Health Risk |
Pathogenic |
Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency, Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency |
| RS1568518113 |
CACNA1A
|
Health Risk |
Likely pathogenic |
— |
| RS1568518139 |
CACNA1A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1568523662 |
TCF4
|
Health Risk |
Pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS1568523843 |
CACNA1A
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia type 6, Inborn genetic diseases |
| RS1568523935 |
SLC25A42
|
Health Risk |
Likely pathogenic |
SLC25A42-related mitochondrial encephalomyopathy, SLC25A42-related mitochondrial encephalomyopathy |
| RS1568524980 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital multicore myopathy with external ophthalmoplegia, Central core myopathy |
| RS1568528144 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS1568528171 |
CEACAM16
|
Health Risk |
Pathogenic |
Hearing loss, autosomal recessive 113 |
| RS1568528185 |
SLC4A11
|
Health Risk |
Likely pathogenic |
Corneal dystrophy-perceptive deafness syndrome, Congenital hereditary endothelial dystrophy of cornea |
| RS1568528298 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS1568528491 |
SMARCA4
|
Health Risk |
Pathogenic |
SMARCA4-related disorder, Rhabdoid tumor predisposition syndrome 2 |
| RS1568530396 |
ERCC2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1568530415 |
SLC7A9
|
Health Risk |
Pathogenic |
Cystine urolithiasis, Cystine urolithiasis |
| RS1568530776 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS1568532361 |
CSNK2A1
|
Health Risk |
Pathogenic |
Okur-Chung neurodevelopmental syndrome, Okur-Chung neurodevelopmental syndrome |
| RS1568532461 |
SLC7A9
|
Health Risk |
Likely pathogenic |
— |
| RS1568537774 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Central core disease, autosomal recessive |
| RS1568539909 |
RYR1
|
Health Risk |
Pathogenic/Likely pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS1568539930 |
SLC4A11
|
Health Risk |
Pathogenic |
— |
| RS1568546120 |
ERCC2
|
Health Risk |
Pathogenic |
Xeroderma pigmentosum, group D |
| RS1568546252 |
ERCC2
|
Health Risk |
Pathogenic |
Xeroderma pigmentosum, group D |
| RS1568546568 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 42 |
| RS1568546593 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS1568547326 |
CPT1C
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 73, Hereditary spastic paraplegia 73 |
| RS1568548317 |
IDH3B
|
Health Risk |
Likely pathogenic |
— |
| RS1568549310 |
RYR1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1568550769 |
PANK2
|
Health Risk |
Pathogenic |
Pigmentary pallidal degeneration, Retinal dystrophy |
| RS1568554484 |
COMP
|
Health Risk |
Likely pathogenic |
— |
| RS1568554654 |
RBCK1
|
Health Risk |
Pathogenic |
Polyglucosan body myopathy type 1, Polyglucosan body myopathy type 1 |
| RS1568554988 |
COMP
|
Health Risk |
Likely pathogenic |
Multiple epiphyseal dysplasia type 1, Multiple epiphyseal dysplasia type 1 |
| RS1568560821 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS1568562752 |
RYR1
|
Health Risk |
Pathogenic/Likely pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS1568565786 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS1568566883 |
MEGF8
|
Health Risk |
Pathogenic |
MEGF8-related Carpenter syndrome, MEGF8-related Carpenter syndrome |
| RS1568569290 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 42 |
| RS1568569941 |
PANK2
|
Health Risk |
Pathogenic |
Pigmentary pallidal degeneration, Pigmentary pallidal degeneration |
| RS1568570002 |
PANK2
|
Health Risk |
Pathogenic |
Pigmentary pallidal degeneration, Pigmentary pallidal degeneration |
| RS1568571093 |
PLCB1
|
Health Risk |
Pathogenic |
— |
| RS1568573490 |
SIPA1L3
|
Health Risk |
Pathogenic |
Cataract 45, Cataract 45 |
| RS1568574634 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Migraine, familial hemiplegic |
| RS1568574931 |
PANK2
|
Health Risk |
Pathogenic |
Pigmentary pallidal degeneration, Pigmentary pallidal degeneration |
| RS1568574966 |
PLCB1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 12 |
| RS1568575238 |
PANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Pigmentary pallidal degeneration, Pigmentary pallidal degeneration |
| RS1568575271 |
PANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Pigmentary pallidal degeneration, Pigmentary pallidal degeneration |
| RS1568576386 |
RYR1
|
Health Risk |
Pathogenic/Likely pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS1568577135 |
PLCB1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 12 |
| RS1568578781 |
RFXANK
|
Health Risk |
Pathogenic |
MHC class II deficiency, MHC class II deficiency |
| RS1568579235 |
RFXANK
|
Health Risk |
Likely pathogenic |
MHC class II deficiency, MHC class II deficiency 2 |
| RS1568579997 |
RFXANK
|
Health Risk |
Likely pathogenic |
MHC class II deficiency, RFXANK-related disorder |
| RS1568581720 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS1568582347 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS1568582652 |
LDLR
|
Health Risk |
Pathogenic |
Familial hypercholesterolemia, Homozygous familial hypercholesterolemia |
| RS1568582893 |
RYR1
|
Health Risk |
Pathogenic/Likely pathogenic |
Central core myopathy, Congenital myopathy with fiber type disproportion |
| RS1568583728 |
RYR1
|
Health Risk |
Pathogenic |
Congenital multicore myopathy with external ophthalmoplegia, Congenital multicore myopathy with external ophthalmoplegia |
| RS1568583900 |
RYR1
|
Health Risk |
Likely pathogenic |
— |
| RS1568584027 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS1568584452 |
RYR1
|
Health Risk |
Pathogenic |
— |
| RS1568587495 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS1568590155 |
CCDC8
|
Health Risk |
Pathogenic |
3M syndrome 3, 3M syndrome 3 |
| RS1568591803 |
RYR1
|
Health Risk |
Likely pathogenic |
RYR1-related disorder, Central core myopathy |
| RS1568591929 |
LDLR
|
Health Risk |
Likely pathogenic |
Familial hypercholesterolemia, Hypercholesterolemia |
| RS1568592055 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1568593747 |
RYR1
|
Health Risk |
Likely pathogenic |
— |
| RS1568593906 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS1568593922 |
RYR1
|
Health Risk |
Pathogenic/Likely pathogenic |
RYR1-related disorder, Malignant hyperthermia |
| RS1568593984 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Central core myopathy, Central core myopathy |
| RS1568594068 |
RYR1
|
Health Risk |
Pathogenic/Likely pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS1568594903 |
LDLR
|
Health Risk |
Pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS1568595930 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS1568596962 |
LDLR
|
Health Risk |
Likely pathogenic |
— |
| RS1568600184 |
PRPF31
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 11, Retinitis pigmentosa 11 |
| RS1568600328 |
LDLR
|
Health Risk |
Likely pathogenic |
Familial hypercholesterolemia, Hypercholesterolemia |
| RS1568600415 |
LDLR
|
Health Risk |
Pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS1568600459 |
LDLR
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS1568601643 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, RYR1-related disorder |
| RS1568604251 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, RYR1-related disorder |